A Drug for Still’s Disease Has Been Approved in Europe
Source: Pixabay

A Drug for Still’s Disease Has Been Approved in Europe

A drug called Kineret has been approved by the European Commission in 28 European countries for the treatment of both adult-onset and juvenile-onset Still’s disease, reports Check Orphan. Still’s disease…

Continue Reading A Drug for Still’s Disease Has Been Approved in Europe
New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
source: pixabay.com

New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.

According to a story from globenewswire.com, the pharmaceutical companies Ultragenyx and Kyowa Kirin recently issued an announcement that the U.S. FDA has granted approval to their new treatment Crysvita (burosumab-twza).…

Continue Reading New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
A Potential Gene Therapy for Duchenne Muscular Dystrophy Has Just Begun Patient Testing
Source: Pixabay

A Potential Gene Therapy for Duchenne Muscular Dystrophy Has Just Begun Patient Testing

Pfizer has just begun a medical trial for a potential gene therapy treatment for Duchenne muscular dystrophy, and the first patient has been dosed. Click here to read the original…

Continue Reading A Potential Gene Therapy for Duchenne Muscular Dystrophy Has Just Begun Patient Testing
$5 Million Has Been Donated to Treat Childhood Cancers by a Foundation Set Up by Parents
Source: Pixabay

$5 Million Has Been Donated to Treat Childhood Cancers by a Foundation Set Up by Parents

A $5 million charitable donation from the Isabella Santos Foundation has been committed to the Atrium Health’s Levine Children’s Hospital, reports FinacialContent. It will be used to establish The Isabella…

Continue Reading $5 Million Has Been Donated to Treat Childhood Cancers by a Foundation Set Up by Parents
The Ability to Monitor Lung Function From Home is Overwhelmingly Popular, Survey Finds
Source: Pixabay

The Ability to Monitor Lung Function From Home is Overwhelmingly Popular, Survey Finds

An online patient survey has found that 96% of pulmonary fibrosis patients, and 93% of cystic fibrosis patients, support being able to monitor their lung function at home between visits…

Continue Reading The Ability to Monitor Lung Function From Home is Overwhelmingly Popular, Survey Finds